1. 1. Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209-249. (PMID: 33538338) [Crossref]
2. 2. Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, et al. Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black-White Crossover. J Natl Cancer Inst 2012; 104: 1094-1101. (PMID: 22773826) [Crossref]
3. 3. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22: 1736-1747. (PMID: 21709140) [Crossref]
4. 4. Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004. Cancer Epidemiol Biomarkers Prev 2009; 18: 1763-1769. (PMID: 19454615) [Crossref]
5. 5. Copyright. Robbins and Cotran Pathologic Basis of Disease 2010. https://www.nobelkitabevi.com.tr/patoloji-/9375-robbins-cotran-pathologic-basis-of-disease-10th-edition-9780323609920.html [Crossref]